Ranking Alexa Global: # 3,453,643
The main IP address: 193.62.203.106,Your server United Kingdom,Cambridge ISP:European Bioinformatics Institute TLD:uk CountryCode:GB
The description :wellcome trust case control consortium home wtccc1 wtccc2 wtccc3 press & publications press release: 28/09/2005 press release: 06/06/2007 publications and presentations data access access to data...
This report updates in 01-Dec-2018
Created Date: | 2005-12-01 |
Changed Date: | 2016-02-10 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host wtccc.org.uk. Currently, hosted in United Kingdom and its service provider is European Bioinformatics Institute .
Latitude: | 51.733329772949 |
Longitude: | -2.3666698932648 |
Country: | United Kingdom (GB) |
City: | Cambridge |
Region: | England |
ISP: | European Bioinformatics Institute |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called containing the details of what the browser wants and will accept back from the web server.
X-XSS-Protection: | 1; mode=block |
Transfer-Encoding: | chunked |
Public-Key-Pins-Report-Only: | pin-sha256="C3595NSCDCAiqcNNiiRxWGKC/HvcjajF5sP5OjTR9Zw="; pin-sha256="NHWInGPcQsxATCvyKq13mvlLhcewT5nt5ug9S5BKEow="; pin-sha256="OZCNmn0TuQu2Hlc0PpGZIyVWfCzerktrW1quVeQXvPQ="; pin-sha256="YLh1dUR9y6Kja30RrAn7JKnbQG/uEtLMkBgFF2Fuihg="; pin-sha256="YLh1dUR9y6Kja30RrAn7JKnbQG/uEtLMkBgFF2Fuihg="; pin-sha256="aySmdltqYUP/2dSy9UjGaNklswuXbqSxzPSj0mABJ68="; max-age=5184000; report-uri="https://report-uri.sanger.ac.uk/report-uri" |
Cache-control: | no-cache |
Content-Style-Type: | text/css |
X-Frame-Options: | SAMEORIGIN |
X-Pagesmith-Debug: | web-wwwmicrosites-02:7740/22745 |
Expires: | Sat, 01 Dec 2018 06:39:45 GMT |
Keep-Alive: | timeout=15, max=100 |
X-Olaf: | ⛄ |
Pragma: | no-cache |
Date: | Sat, 01 Dec 2018 06:39:45 GMT |
Content-Script-Type: | text/javascript |
Language: | en-GB |
Strict-Transport-Security: | max-age=31536000 |
Connection: | Keep-Alive |
X-Content-Type-Options: | nosniff |
Content-Encoding: | gzip |
Vary: | Accept, Accept-Encoding |
X-UA-Compatible: | IE=edge |
X-Pagesmith-CacheFlag: | hit |
X-Clacks-Overhead: | GNU Terry Pratchett |
Referrer-Policy: | strict-origin-when-cross-origin |
Content-Type: | text/html; charset=utf-8 |
soa: | dns1.sanger.ac.uk. postmaster.sanger.ac.uk. 2011013015 10800 3600 2419200 900 |
ns: | dns4.sanger.ac.uk. dns1.sanger.ac.uk. dns2.sanger.ac.uk. |
ipv4: | IP:193.62.203.106 ASN:786 OWNER:JANET Jisc Services Limited, GB Country:GB IP:193.62.203.105 ASN:786 OWNER:JANET Jisc Services Limited, GB Country:GB |
mx: | MX preference = 10, mail exchanger = mxa-002f8a01.gslb.pphosted.com. MX preference = 10, mail exchanger = mxb-002f8a01.gslb.pphosted.com. |
wellcome trust case control consortium home wtccc1 wtccc2 wtccc3 press & publications press release: 28/09/2005 press release: 06/06/2007 publications and presentations data access access to data approved applications cdac members data formats faq open access available software participant access participant login contact feedback and queries wtccc1 the wellcome trust case control consortium (wtccc) is a group of 50 research groups across the uk which was established in 2005. the wtccc aims were to exploit progress in understanding of patterns of human genome sequence variation along with advances in high-throughput genotyping technologies, and to explore the utility, design and analyses of genome-wide association (gwa) studies. the wtccc has substantially increased the number of genes known to play a role in the development of some of our most common diseases and has to date identified approximately 90 new variants across all of the diseases analysed. as well as confirming many of the known associations, some 28 in total, the wtccc has also identified many novel variants that affect susceptibility to disease. overview the wtccc1 studies the wtccc aims to complete the initial survey of common variation for association to disease, and to examine the replicated association signals detected through resequencing and fine-mapping. the wtccc will also carry out a major experiment to address the genome-wide measurement of copy number variation (cnv) within the 19,000 samples tested in phase one (16,000 disease samples and 3,000 common controls) and additional samples from breast cancer. further information wtccc2 in recognition of the success of the wtccc and to capitalise on the success of the gwa approach, a further round of gwa studies were funded in april 2008. these include 15 wtccc-collaborative studies and 12 independent studies be supported totalling approximately 120,000 samples. many of the studies represent major international collaborative networks that have together assembled large sample collections. wtccc2 will perform genome-wide association studies in 13 disease conditions: ankylosing spondylitis, barrett's oesophagus and oesophageal adenocarcinoma, glaucoma, ischaemic stroke, multiple sclerosis, pre-eclampsia, parkinson's disease, psychosis endophenotypes, psoriasis, schizophrenia, ulcerative colitis and visceral leishmaniasis. wtccc2 will also investigate the genetics of reading and mathematics abilities in children and the pharmacogenomics of statin response. over 60,000 samples will be analysed using either the affymetrix v6.0 chip or the illumina 660k chip. the wtccc2 will also genotype 3,000 controls each from the 1958 british birth cohort and the uk blood service control group, and the 6,000 controls will be genotyped on both the affymetrix v6.0 and illumina 1.2m chips. the wtccc2 studies wtccc3 to build further on the success of the gwas approach demonstrated by the wtccc, the wellcome trust has provided support for a further round of gwa studies in january 2009. these include 5 wtccc-collaborative studies to be carried out in wtccc3 and 5 independent studies, across a range of diseases. many of the studies represent major international collaborative networks that have together assembled large sample collections. wtccc3 will perform genome-wide association studies in the following 4 disease conditions: primary biliary cirrhosis, anorexia nervosa, pre-eclampsia in uk subjects, and the interactions between donor and recipient dna related to early and late renal transplant dysfunction. the wtccc3 will also carry out a pilot in a study of the genetics of host control of hiv-1 infection. over 40,000 samples will be analysed using the illumina 660k chip. the wtccc3 will utilise the 6,000 control genotypes generated by the wtccc2. the wtccc3 studies data release genotype data from wtccc1 is available by application to the consortium data access committee ( [email protected] ). to support the studies within wtccc and also the independent studies, the wtccc will first genotype 6,000 common controls; 3,000 from the 1958 british birth cohort and 3,000 from the uk blood service collection, and the data will be made available immediately through the existing controlled data access mechanism of the wtccc. data generated from the disease samples in wtccc2 will be made available six months after data generation and qc, or upon publication. cookies policy | terms & conditions. this site is hosted by the wellcome sanger institute .
https://www.wtccc.org.uk/info/approved_applications.html
https://www.wtccc.org.uk/info/070606.html
https://www.wtccc.org.uk/ccc2/
https://www.wtccc.org.uk/info/data_formats.html
https://www.wtccc.org.uk/info/050928.html
https://www.wtccc.org.uk/info/faq.html
https://www.wtccc.org.uk/ccc1/plus_typing_array.html
https://www.wtccc.org.uk/participant.html
https://www.wtccc.org.uk/info/cdac_members.html
https://www.wtccc.org.uk/cookiespolicy.html
https://www.wtccc.org.uk/info/access_to_data_samples.html
https://www.wtccc.org.uk/ccc2/wtccc2_studies.html
https://www.wtccc.org.uk/s-inst/legal.html
https://www.wtccc.org.uk/ccc1/
https://www.wtccc.org.uk/index.html
sanger.ac.uk
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain name:
wtccc.org.uk
Registrant:
Genome Research Ltd
Registrant type:
UK Registered Charity, (Charity number: 2742969)
Registrant's address:
Wellcome Trust Sanger Institute
Wellcome Trust Genome Campus
Hinxton
Cambridgeshire
CB10 1SA
United Kingdom
Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 23-Sep-2013
Registrar:
123-Reg Limited t/a 123-reg [Tag = 123-REG]
URL: http://www.123-reg.co.uk
Relevant dates:
Registered on: 01-Dec-2005
Expiry date: 01-Dec-2017
Last updated: 10-Feb-2016
Registration status:
Registered until expiry date.
Name servers:
dns1.sanger.ac.uk
dns2.sanger.ac.uk
dns3.sanger.ac.uk
dns4.sanger.ac.uk
WHOIS lookup made at 11:37:04 14-Sep-2017
--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REFERRER http://www.nominet.org.uk
REGISTRAR Nominet UK
SERVERS
SERVER uk.whois-servers.net
ARGS wtccc.org.uk
PORT 43
TYPE domain
OWNER
ORGANIZATION Genome Research Ltd
TYPE
UK Registered Charity, (Charity number: 2742969)
ADDRESS
Wellcome Trust Sanger Institute
Wellcome Trust Genome Campus
Hinxton
Cambridgeshire
CB10 1SA
United Kingdom
Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 23-Sep-2013
DOMAIN
SPONSOR 123-Reg Limited t/a 123-reg [Tag = 123-REG]
CREATED 2005-12-01
CHANGED 2016-02-10
STATUS
Registered until expiry date.
NSERVER
DNS1.SANGER.AC.UK 193.62.203.30
DNS2.SANGER.AC.UK 193.62.203.31
DNS3.SANGER.AC.UK (DOES NOT EXIST)
DNS4.SANGER.AC.UK 212.110.172.59
NAME wtccc.org.uk
DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .